Valuation Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 12:32:10 10/07/2025 pm IST			5-day change	1st Jan Change
444.40 ^DKK	+0.30%		+0.35%	-29.02%

09/07	Major deals involving U.S. drugmakers and biotechs over the past decade	RE
09/07	European shares close at four-week high on banks boost; US trade talks in focus	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	9,86,612	16,74,992	21,18,803	31,12,331	27,72,285	19,66,722	-	-
Change	-	69.77%	26.5%	46.89%	-10.93%	-29.06%	-	-
Enterprise Value (EV) ¹	9,84,211	16,84,152	21,21,013	31,09,107	28,48,764	20,30,913	20,01,534	19,73,704
Change	-	71.12%	25.94%	46.59%	-8.37%	-28.71%	-1.45%	-1.39%
P/E ratio	23.7x	35.4x	38.4x	37.5x	27.6x	17x	14.4x	12.8x
PBR	15.8x	24x	25.6x	29.4x	19.3x	9.6x	7.73x	6.27x
PEG	-	2.3x	2.2x	0.7x	1.3x	1.1x	0.8x	1x
Capitalization / Revenue	7.77x	11.9x	12x	13.4x	9.55x	5.94x	5.18x	4.68x
EV / Revenue	7.75x	12x	12x	13.4x	9.81x	6.13x	5.27x	4.7x
EV / EBITDA	16.4x	26x	25.8x	27.8x	19.3x	12.2x	10.3x	9.12x
EV / EBIT	18.2x	28.7x	28.4x	30.3x	22.2x	13.5x	11.4x	10.1x
EV / FCF	34.5x	57.4x	37x	45.5x	38.6x	30.6x	19.7x	15.6x
FCF Yield	2.9%	1.74%	2.7%	2.2%	2.59%	3.27%	5.06%	6.39%
Dividend per Share ²	4.55	5.2	6.2	9.4	11.4	13.19	15.36	17.06
Rate of return	2.13%	1.41%	1.32%	1.35%	1.83%	2.98%	3.47%	3.85%
EPS ²	9.005	10.37	12.22	18.62	22.63	26.08	30.79	34.66
Distribution rate	50.5%	50.1%	50.7%	50.5%	50.4%	50.6%	49.9%	49.2%
Net sales ¹	1,26,946	1,40,800	1,76,954	2,32,261	2,90,403	3,31,168	3,79,729	4,20,370
EBITDA ¹	59,879	64,669	82,171	1,11,987	1,47,446	1,65,956	1,93,393	2,16,304
EBIT ¹	54,126	58,644	74,809	1,02,574	1,28,339	1,50,185	1,75,554	1,95,398
Net income ¹	42,138	47,757	55,525	83,683	1,00,988	1,16,422	1,37,121	1,53,582
Net Debt ¹	-2,401	9,160	2,210	-3,224	76,479	64,191	34,812	6,982
Reference price ²	213.32	367.50	469.00	698.10	624.20	443.05	443.05	443.05
Nbr of stocks (in thousands)	46,24,923	45,57,801	45,17,704	44,58,288	44,41,340	44,39,053	-	-
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	16.99x	6.13x	12.24x	2.98%	31TCr
ELI LILLY AND COMPANY	37.01x	12.23x	27.9x	0.75%	71TCr
JOHNSON & JOHNSON	14.98x	4.17x	11.47x	3.36%	38TCr
ABBVIE INC.	27.01x	6.54x	13.6x	3.44%	34TCr
ROCHE HOLDING AG	14.32x	3.51x	8.7x	3.79%	26TCr
NOVARTIS AG	17.39x	4.7x	11.37x	3.21%	24TCr
ASTRAZENECA PLC	22.25x	4.15x	12.2x	2.28%	22TCr
MERCK & CO., INC.	10.73x	3.48x	7.5x	3.84%	21TCr
AMGEN INC.	22.55x	5.8x	11.25x	3.23%	16TCr
PFIZER, INC.	12.08x	2.94x	7.28x	6.68%	15TCr
Average	19.53x	5.36x	12.35x	3.36%	29.63TCr
Weighted average by Cap.	22.44x	6.52x	15.01x	2.84%